MDS
Clinical trials for MDS explained in plain language.
Never miss a new study
Get alerted when new MDS trials appear
Sign up with your email to follow new studies for MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Pill may replace shots for elderly blood cancer patients
Disease control CompletedThis study tested an oral version of the drug azacitidine (CC-486) in 11 elderly patients with higher-risk myelodysplastic syndromes (MDS) who had already improved with injectable azacitidine. The goal was to see if the oral pill could safely maintain that improvement and make tr…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: University of Florence • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug LYT-200 tested in patients with relapsed blood cancers
Disease control CompletedThis early-stage study tested a new drug called LYT-200 in 101 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had returned or stopped responding to treatment. The main goal was to check the drug's safety and find the right dose. Researchers …
Matched conditions: MDS
Phase: PHASE1 • Sponsor: PureTech • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New DNA test aims to predict cancer return before it happens
Knowledge-focused CompletedThis study followed 308 people with MDS (a bone marrow disorder) who had a stem cell transplant. Researchers looked for unique genetic mutations in each patient's cancer cells and checked for those mutations in blood and bone marrow samples after transplant. The goal was to see i…
Matched conditions: MDS
Sponsor: Nordic MDS Group • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC